Foreign investment gap narrows

Investments by Israelis abroad grew more than twice as fast as foreign investments in Israel in the first nine months of the year, according to data released Monday by the Bank of Israel.

By DANIEL KENNEMER
December 20, 2005 07:51

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user uxperience almost completely free of ads
  • Access to our Premium Section and our monthly magazine to learn Hebrew, Ivrit
  • Content from the award-winning Jerusalem Repor
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later Don't show it again

Investments by Israelis abroad grew more than twice as fast as foreign investments in Israel in the first nine months of the year, according to data released Monday by the Bank of Israel. Investments by Israelis abroad balanced at $113 billion at the end of September, up $12.5b., or 11.1 percent, from the beginning of the year, while the balance of foreign investments in Israel came to $142b., some $7.1b., or 5%, more than at the beginning of the year. The central bank attributed the increase in Israeli investments abroad to the interest rate gap and differences in tax rates, and the increase in foreign investments in Israel to the country's growing economic attractiveness, the recovery of world capital markets, and the increased flow of capital to emerging markets.

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS